Orally administered factor xa inhibitor, rivaroxaban: a novel thromboembolic prophylaxis agent.

作者: RICARDO J. KOMOTAR , ROBERT M. STARKE , E. SANDER CONNOLLY

DOI: 10.1227/01.NEU.0000339454.55968.F0

关键词:

摘要:

参考文章(23)
Andrew T. Chan, Andrew Atiemo, Linda K. Diran, Gregory P. Licholai, Peter McLaren Black, Mark A Creager, Samuel Z. Goldhaber, Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. Journal of Thrombosis and Thrombolysis. ,vol. 8, pp. 139- 142 ,(1999) , 10.1023/A:1008915202859
Giancarlo Agnelli, Franco Piovella, Pio Buoncristiani, Paolo Severi, Mario Pini, Armando D'Angelo, Chiara Beltrametti, Marcello Damiani, Gian Carlo Andrioli, Raffaelino Pugliese, Alfonso Iorio, Gianluigi Brambilla, Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. The New England Journal of Medicine. ,vol. 339, pp. 80- 85 ,(1998) , 10.1056/NEJM199807093390204
Mark G. Hamilton, Russell D. Hull, Graham F. Pineo, Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery. ,vol. 34, pp. 280- 296 ,(1994) , 10.1227/00006123-199402000-00012
Raymond E. Sawaya, B. Lee Ligon, Thromboembolic complications associated with brain tumors Journal of Neuro-Oncology. ,vol. 22, pp. 173- 181 ,(1994) , 10.1007/BF01052892
R. Cheruku, E. Tapazoglou, J. Ensley, J. A. Kish, G. D. Cummings, M. Al-Sarraf, The Incidence and significance of thromboembolic complications in patients with high-grade gliomas Cancer. ,vol. 68, pp. 2621- 2624 ,(1991) , 10.1002/1097-0142(19911215)68:12<2621::AID-CNCR2820681218>3.0.CO;2-7
O. E. Dahl, A. M. Pleil, Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement. Journal of Thrombosis and Haemostasis. ,vol. 1, pp. 896- 906 ,(2003) , 10.1046/J.1538-7836.2003.00236.X
David M. Frim, Fred G. Barker, Charles E. Poletti, Allan J. Hamilton, Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery. ,vol. 30, pp. 830- 833 ,(1992) , 10.1227/00006123-199206000-00002
Bengt I Eriksson, Lars C Borris, Richard J Friedman, Sylvia Haas, Menno V Huisman, Ajay K Kakkar, Tiemo J Bandel, Horst Beckmann, Eva Muehlhofer, Frank Misselwitz, William Geerts, None, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty The New England Journal of Medicine. ,vol. 358, pp. 2765- 2775 ,(2008) , 10.1056/NEJMOA0800374
Dagmar Kubitza, Michael Becka, Georg Wensing, Barbara Voith, Michael Zuehlsdorf, Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects. European Journal of Clinical Pharmacology. ,vol. 61, pp. 873- 880 ,(2005) , 10.1007/S00228-005-0043-5